Mayka Sanchez: Updates from EFAPH 2026 Meeting
Mayka Sanchez, Associate Professor and Senior Group Leader at International University of Catalonia, shared a post on LinkedIn:
“Great to be in Dublin for the annual meeting of European Federation of Associations of Patients with Haemochromatosis (EFAPH), bringing together patient representatives, clinicians, and researchers committed to improving care for people living with haemochromatosis.
The meeting included an excellent Clinical Expert Session featuring a keynote presentation by Domenico Girelli, alongside an update on the CSL Ferroclear haemochromatosis clinical trial project and its potential implications for future treatment options.
A valuable opportunity to exchange knowledge, strengthen collaborations, and discuss the future of haemochromatosis research and patient care.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering